Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility

Blalock, 1994, The syntax of immune-neuroendocrine communication, Immunol Today, 15, 504, 10.1016/0167-5699(94)90205-4 Miyata, 1989, Isolation of a novel 38 residue-hypothalamic polypeptide which simulates adenylate cyclase in pituitary cells, Biochem Biophys Res Comm, 164, 567, 10.1016/0006-291X(89)91757-9 Arimura, 1992, Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research, Regul Pept, 37, 287, 10.1016/0167-0115(92)90621-Z Gaytan, 1994, Pituitary adenylate cyclase-activating peptide (PACAP) immuno-localization in lymphoid tissues of the rat, Cell Tissue Res, 276, 233, 10.1007/BF00306107 Tatsuno, 1991, Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase-activating polypeptide: a comparative study with vasoactive intestinal peptide, Endocrinology, 128, 728, 10.1210/endo-128-2-728 Ichinose, 1995, Enhancement of phagocytosis in mouse macrophages by pituitary adenylate cyclase activating polypeptide (PACAP) and related peptides, Immunopharmacology, 30, 217, 10.1016/0162-3109(95)00025-O Delgado, 1995, Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP, J Neuroimmunol, 62, 137, 10.1016/0165-5728(95)00105-6 Delgado, 1996, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis, Blood, 87, 5152, 10.1182/blood.V87.12.5152.bloodjournal87125152 Cauvin, 1991, Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord, Regul Pept, 35, 161, 10.1016/0167-0115(91)90478-Y Shivers, 1991, Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions, Endocrinology, 128, 3055, 10.1210/endo-128-6-3055 O'Dorisio, 1981, Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase, J Immunol, 127, 2551 Rawlings, 1994, PACAP, PACAP receptors, and intracellular signalling, Mol Cell Endocrinol, 101, C5, 10.1016/0303-7207(94)90212-7 Rawlings, 1994, Pituitary adenylate cyclase activating polypeptide increases [Ca2+]i in rat gonadotrophs throgh an inositol triphosphate-dependent mechanism, J Biol Chem, 269, 5680, 10.1016/S0021-9258(17)37514-2 Doherty, 1987, Human monocyte adherence: A primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium, J Immunol, 138, 1762 Springer, 1990, Adhesion receptors of the immune system, Nature, 346, 425, 10.1038/346425a0 Mackay, 1993, Cell adhesion in the immune system, Immunol Today, 14, 99, 10.1016/0167-5699(93)90205-Y De la Fuente, 1993, Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function in rat peritoneal macrophages, 48, 347 De la Fuente, 1994, Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages, Peptides, 15, 1157, 10.1016/0196-9781(94)90137-6 De la Fuente, 1991, Modulation of phagocytic function in murine peritoneal macrophages by bombesin, gastrin-releasing peptide and neuromedin C, Immunology, 73, 205 Noga, 1984, Methods in laboratory investigation: Isolation of guinea pigs monocytes and Kurloff cells, 51, 244 Boyden, 1962, The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes, J Exp Med, 115, 453, 10.1084/jem.115.3.453 Schiffman, 1979, Biochemistry of phagocyte chemotaxis, Curr Top Cell Regul, 15, 203, 10.1016/B978-0-12-152815-7.50010-7 Schubert, 1989, N-formyl-Met-Leu-Phe induced accumulation of inositol triphosphates indicates the presence of oligopeptide chemoattractant receptors on circulating human lymphocytes, FEBS Lett, 257, 174, 10.1016/0014-5793(89)81814-9 Boige, 1984, Forskolin stimulates adenylate cyclase in human colonic crypts: Interaction with VIP, Eur J Pharmacol, 101, 111, 10.1016/0014-2999(84)90036-0 Taffet, 1983, Retinal inhibits TPA activated calcium-dependent, phospholipid-dependent protein kinase C, Biochem Biophys Res Comm, 114, 1194, 10.1016/0006-291X(83)90689-7 Waelbroeck, 1985, Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas, 116, 2643 Unanue, 1987, The basis for the immunoregulatory role of macrophages and other accessory cells, Science, 236, 551, 10.1126/science.2437650 Christophe, 1993, Type I receptors for PACAP (a neuropeptide even more important than VIP?), Biochim Biophys Acta, 1154, 183, 10.1016/0304-4157(93)90011-C Ottaway, 1992, Receptors for vasoactive intestinal peptide on murine lymphocytes turn over rapidly, J Neuroimmunol, 38, 241, 10.1016/0165-5728(92)90017-F Haskill, 1988, Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes, J Immunol, 140, 1690 De la Fuente, 1993, Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY, 80, 259 De la Fuente, 1993, Stimulation of phagocytic function in mouse macrophages by neurotensin and neuromedin N, J Neuroimmunol, 42, 97, 10.1016/0165-5728(93)90216-L Garrido, 1992, Modulation of neurotensin and neuromedin N of adherence and chemotaxis capacity of murine lymphocytes, Regul. Pept., 41, 27, 10.1016/0167-0115(92)90511-R De la Fuente, 1995, Inhibition of murine peritoneal macrophage functions by sulfated cholecystokinin octapeptide, Regul Pept, 55, 47, 10.1016/0167-0115(94)00091-B Bondesson, 1991, Dual effects of vasoactive intestinal peptide (VIP) on leukocyte migration, Acta Physiol Scand, 141, 477, 10.1111/j.1748-1716.1991.tb09108.x Sacerdote, 1987, Vasoactive intestinal peptide 1–12: a ligand for the CD4 (T4)/human immunodeficiency virus receptor, J Neurosci Res, 18, 102, 10.1002/jnr.490180117 Del Rio, 1994, Chemoattractant capacity of bombesin, gastrin-releasing peptide and neuromedin C is mediated through PKC activation in murine peritoneal leukocytes, Regul Pept, 49, 185, 10.1016/0167-0115(94)90140-6 Ruff, 1985, Substance P receptor-mediated chemotaxis of human monocytes, Peptides, 6, 107, 10.1016/0196-9781(85)90142-1 Bourne, 1974, Modulation of inflammation and immunity by cyclic AMP, Science, 184, 19, 10.1126/science.184.4132.19 Gallin, 1978, Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion, J Immunol, 120, 492 Pryzwansky, 1981, Compartmentalization of cyclic AMP during phagocytosis by human neutrophilic granulocytes, Science, 211, 407, 10.1126/science.6261328 Wirth, 1982, Inhibitory action of elevated levels of adenosine-3′:5′ cyclic monophosphate on phagocytosis: effects on macrophage-trypanosoma cruzi interaction, J Immunol, 129, 2759 Rivkin, 1975, The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils, J Immunol, 115, 1126 Scheiner, 1975, The modulation of spontaneous and anti-Ig-stimulated mobility of lymphocytes by cyclic nucleotides and adrenergic and cholinergic agents, J Immunol, 114, 802 Moore, 1982, Cyclic AMP reduces and cyclic GMP increases the traffic of lymphocytes through peripheral lymph node of sheep in vivo, Immunology, 47, 423 Hatch, 1977, Cyclic nucleotic changes in human neutrophils induced by chemoattractants and chemotactic modulators, J Immunol, 119, 450 Smith, 1971, Human lymphocyte metabolism, 50, 442 Watson, 1976, The involvement of cyclic nucleotide metabolism in the initiation of lymphocyte proliferation induced by mitogens, J Immunol, 117, 1656 Betz, 1991, PGE2 inhibits production of TH1 but not TH2 lymphokines, J Immunol, 146, 108 Iwaz, 1986, Elevation of cyclic 3′5′ adenosine monophosphate levels by cholera toxin inhibits the generation of interleukin-2 activity, Cell Immunol, 102, 455, 10.1016/0008-8749(86)90105-X Calvo, 1986, Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: Specific binding and cyclic AMP production, Gen Pharmacol, 17, 185, 10.1016/0306-3623(86)90137-0 Gomariz, 1994, Gene expression of VIP receptor in rat lymphocytes, Biochem Biophys Res Comm, 203, 1599, 10.1006/bbrc.1994.2369 Guerrero, 1981, Interaction of vasoactive intestinal peptide with human blood mononuclear cells, Mol Cell Endocrinol, 21, 151, 10.1016/0303-7207(81)90052-6 Calvo, 1994, Expression of VIP receptors in mouse peritoneal macrophages: Functional and molecular characterization, J Neuroimmunol, 50, 85, 10.1016/0165-5728(94)90218-6 Segura, 1991, Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages, Regul Pept, 33, 133, 10.1016/0167-0115(91)90208-X Delgado, 1996, Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages, Regul Pept, 62, 161, 10.1016/0167-0115(96)00024-9 Ishihara, 1992, Functional expression and tissue distribution of a novel receptor for VIP, Neuron, 8, 811, 10.1016/0896-6273(92)90101-I Tseng, 1989, Mechanism of vasoactive intestinal peptide (VIP)-mediated immunoregulation, 95 Nishizuka, 1986, Studies and perspectives of protein kinase C, Science, 233, 305, 10.1126/science.3014651 Beckner, 1988, Potentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase, J Immunol, 140, 208 Bareis, 1982, Phospholipid metabolism, calcium flux and the receptor mediated induction of chemotaxis in rabbit neutrophils, J Cell Biol, 93, 690, 10.1083/jcb.93.3.690 Snyderman, 1984, Chemoattractant receptors on phagocytic cells, Annu Rev Immunol, 2, 257, 10.1146/annurev.iy.02.040184.001353 Shelly, 1989, Effect of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN), Gen Pharmacol, 20, 329, 10.1016/0306-3623(89)90268-1 Isaad, 1989, Biphasic regulation of macrophage attachment by activators of cyclic adenosine monophosphate-dependent kinase and protein kinase C, J Cell Physiol, 140, 317, 10.1002/jcp.1041400218 Chakder, 1993, The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide: functional and binding studies on opossum internal and sphincter smooth muscle, J Pharmacol Exp Ther, 266, 392 Rodriguez-Pena, 1991, Vasoactive intestinal peptide receptor antagonist in rat seminal vesicle membranes, Eur J Pharmacol, 208, 207, 10.1016/0922-4106(91)90097-2 Martinez, 1996, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes, J Immunol, 156, 4128